指南与共识腹部儿科影像技术与安全MR

炎症性肠病患儿中原发性硬化性胆管炎:ESPGHAN肝病委员会与IBD Porto小组立场文件

Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group.
指南 / 共识 · J Pediatr Gastroenterol Nutr · 2024-12-31

该立场文件由ESPGHAN肝病委员会与IBD Porto小组制定,针对炎症性肠病(IBD)合并原发性硬化性胆管炎(PSC)患儿的诊断、监测与治疗提出循证建议。核心推荐包括:定期筛查γ-谷氨酰转移酶(GGT)以发现胆道疾病,MR胆胰管成像为诊断PSC的首选影像学方法,肝活检用于评估小胆管型PSC或自身免疫性肝炎。文件还涉及熊去氧胆酸、口服万古霉素及免疫调节剂的使用建议,并指出研究空白。

要点

  • MR胆胰管成像(MRCP)是诊断儿童PSC的首选影像学方法。
  • 定期筛查GGT对发现IBD患儿可能的胆道疾病至关重要。
  • 肝活检用于评估小胆管型PSC或自身免疫性肝炎。

核心结论

  • 本立场文件提供了儿童及青少年PSC-IBD的诊断标准、随访策略和治疗策略的最新指导,并指出研究空白。

研究设计与样本

  • ESPGHAN肝病委员会与IBD Porto小组制定的立场文件,核心组提出7个PICO结构化临床问题,由医学图书馆员检索MEDLINE和EMBASE自建库至2022年12月的文献,核心信息形成立场声明后经国际专家(儿科胃肠病学与肝病学、组织病理学、成人胃肠病学与肝病学、放射学、外科)组成的顾问团投票,至少80%同意视为最终声明,其余声明修订后再次在线投票或否决。

诊断标准与关键数值

  • MR胆胰管成像(MRCP)是确立PSC诊断的首选影像学方法。
  • 肝活检在小胆管型PSC或自身免疫性肝炎的评估中有意义。
  • 诊断PSC时无已知IBD的儿童应首先通过粪便钙卫蛋白筛查无症状结肠炎,此后至少每年筛查一次。

临床应用与阅片要点

  • 对IBD患儿应定期筛查γ-谷氨酰转移酶(GGT)以发现可能的胆道疾病。
  • 诊断PSC时无已知IBD的儿童应通过粪便钙卫蛋白筛查无症状结肠炎,此后至少每年一次。
  • 胆汁淤积性肝酶谱的患儿可考虑使用熊去氧胆酸治疗,若GGT有意义的下降或正常化则可继续。
  • 口服万古霉素可能对GGT和肠道炎症有益,但由于缺乏长期研究,推荐审慎使用。
  • PSC-IBD合并自身免疫性肝炎明确特征的患儿可能从皮质类固醇和抗代谢药物中获益。

局限性

  • 口服万古霉素由于缺乏长期研究,推荐审慎使用。
  • 文件指出儿童和青少年PSC-IBD领域存在研究空白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: We aimed to provide an evidence-supported approach to diagnose, monitor, and treat children with inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC).

METHODS: The core group formulated seven PICO-structured clinical questions. A systematic literature search from inception to December 2022 was conducted by a medical librarian using MEDLINE and EMBASE. Core messages from the literature were phrased as position statements and then circulated to a sounding board composed of international experts in pediatric gastroenterology and hepatology, histopathology, adult gastroenterology and hepatology, radiology, and surgery. Statements reaching at least 80% agreement were considered as final. The other statements were refined and then subjected to a second online vote or rejection.

RESULTS: Regular screening for gamma-glutamyltransferase (GGT) is essential for detecting possible biliary disease in children with IBD. MR cholangiopancreatography is the radiological modality of choice for establishing the diagnosis of PSC. Liver biopsy is relevant in the evaluation of small duct PSC or autoimmune hepatitis. Children who do not have known IBD at the time of PSC diagnosis should undergo initial screening with fecal calprotectin for asymptomatic colitis, and then at least once yearly thereafter. Children with a cholestatic liver enzyme profile can be considered for treatment with ursodeoxycholic acid and can continue if there is a meaningful reduction or normalization in GGT. Oral vancomycin may have a beneficial effect on GGT and intestinal inflammation, but judicious use is recommended due to the lack of long-term studies. Children with PSC-IBD combined with convincing features of autoimmune hepatitis may benefit from corticosteroids and antimetabolites.

CONCLUSIONS: We present state-of-the-art guidance on the diagnostic criteria, follow-up strategies, and therapeutic strategies and point out research gaps in children and adolescents with PSC-IBD.

来源:J Pediatr Gastroenterol Nutr,查看原文。版权归原作者所有。

引用

  1. van Rheenen PF, Kolho KL, Russell RK, et al. Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group. J Pediatr Gastroenterol Nutr. 2024. PMID: 39741383. doi:10.1002/jpn3.12378

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。